Resolution of DOJ Investigation Involving Medical Device Manufacturer

ArthroCare Corporation agreed to pay $30 million and entered into a deferred prosecution agreement to end a five-year U.S. Department of Justice (DOJ) securities fraud investigation into whether senior executives defrauded investors. The $30 million represented an almost 50% reduction of the amount of fine that could have been levied against the company under the U.S. Sentencing Guidelines due to its extensive remedial and cooperation efforts. Further, the DOJ did not require a monitor.

ArthroCare Corporation (NASDAQ: ARTC) develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes.

You Also May Be Interested In:

  • Representation of Lineagen, Inc., a provider of molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, in its sale to Bionano Genomics, Inc. (Nasdaq: BNGO), a genome analysis company providing tools and services to scientists and clinicians conducting genetic research and patient testing, for $9.6 million

    We represented Lineagen, Inc., a provider of molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, in...
    Client Type: Private Company
  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Client Type: Private Company
  • Representation of Envision Healthcare Corporation, Inc. in a DOJ/OIG investigation of allegations that allowing physician owners to share in anesthesia profits of Envision’s Folsom, California and Fresno, California ASCs violates the Anti-Kickback Statute.

    Representation of Envision Healthcare Corporation, Inc. in a DOJ/OIG investigation of allegations that allowing physician owners to share in anesthesia...
    Client Type: Private Company